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mRNA levels for the type I and type II isoforms of sarcoplasmic reticulum (SR) Ca-ATPase were determined in soleus (SOL) and extensor digito- 
rum longus (EDL) muscle of euthyroid (normal), hypothyroid, and hyperthyroid rats. Total Ca-ATPase mRNA content of hyperthyroid muscle 
was 1.5-fold (EDL) and 6-fold (SOL) higher compared to hypothyroid muscle, with corresponding increases i  total SR Ca-ATPase activity. EDL 
contained only type II Ca-ATPase mRNA. In SOL type I mRNA was the major form in hypothyroidism (98%), but the type II mRNA content 
was stimulated 150-fold by T3, accounting for 50 % of the Ca-ATPase mRNA in hyperthyroidism. 
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1. INTRODUCTION 
It is now well established that thyroid hormone (T3) 
regulates the sarcoplasmic reticulum (SR) Ca-ATPase 
level in skeletal muscle. This Ca 2 + pump is responsible 
for the re-uptake of cytosolic Ca 2 + released from the 
SR during a contract ion-relaxat ion cycle, and its in- 
crease induced by T3 is in line with the well -known 
stimulative ffect of this hormone on the relaxation 
rate. Measurement of SR Ca-ATPase activity, or coupl- 
ed Ca 2 + -transport, in muscle homogenates or isolated 
SR [1-4,17], as well direct determinat ion of enzyme 
levels [5] and electron microscopy [6] has shown that 
Ca-ATPase levels are increased by T3 up to 6-fold in 
slow muscle and 1.5-fold in fast muscle. Slow muscle 
fibers (type I) express the cardiac isoform of the Ca- 
ATPase (designated type I in this paper), and fast mus- 
cle fibers (type II) express 5 to 7 times higher levels of 
the somewhat more active isoform of the Ca 2 + pump 
(designated type II) [5,14,28]. Both isoforms are encod- 
ed by separate genes [7,8], and it is not known whether 
T3 merely stimulates the expression of the isoform 
already present in a muscle fiber, or that the two 
isoforms are differently affected. Because the 
T3-induced t ransformat ion of type I fibers to fibers 
with fast characteristics includes shifts in isozyme ex- 
pression, e.g. the replacement of myosin isozymes with 
low activity with isoforms typical of type II fibers 
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[9-13], it is possible that the expression of Ca-ATPase 
isozymes is similarly controlled by T~. To test this 
possibility, we determined the mRNA levels for each 
Ca-ATPase isozyme in fast and slow skeletal muscle 
from normal and hypo- and hyperthyroid rats. Because 
it is also unclear whether T3 acts at a pre- or post- 
translat ional  level in st imulating Ca-ATPase levels, we 
determined the maximal SR Ca-ATPase activity of 
these muscles and correlated this with the total levels of 
Ca-ATPase mRNA.  
2. MATERIALS  AND METHODS 
2.1. Animals 
Age-matched male rats of the Wistar strain, weighing 250-300 g at 
the time of sacrifice, were used. Animals were maintained o  a low 
iodine diet with drinking water supplemented with either 6.5 mg 
KI - 1 - ~ (euthyroid control), or 1070 KCIO4 for a period of 6 weeks to 
induce hypothyroidism [15]. Hyperthyroidism was induced by daily 
treatment of euthyroid animals with subcutaneous injections of 20 tg 
T3 per 100 g b.w. for 2 or 4 weeks [16]. Animals were killed with an 
overdose of Nembutal and the soleus (SOL), a typical s ow twitch 
muscle with 80070 type I and 2007o type II fibers, and extensor 
digitorum longus (EDL), a typical fast twitch muscle with 9807o type 
II fibers, were excised an immediately frozen in liquid nitrogen. 
2.2. SR Ca-A TPase activity 
Homogenates of single SOL or EDL muscles were prepared as 
described before [4] and SR Ca-ATPase activity was determined spec- 
trophotometrically (340 nm)as described in detail elsewhere [17]. 
Briefly, homogenate samples were incubated in buffer containing 200 
mM KCI, 15 mM MgCl2, 10mM NAN,, 1 mM EGTA, 0.005% Triton- 
X-100, 20 mM Hepes, 4 mM MgATP, 10 mM phosphoenolpyruvate, 
0.2 mM NADH, 18 U • ml- ~ each of purified pyruvate kinase and 
lactate dehydrogenase (Boehringer), pH 7.5, 25°C. The maximal SR 
Ca-ATPase activity is obtained by recording the ATPase activity in 
the presence of 10 ~tM free [Ca 2+ ] (0.5 mM CaC12), and subtracting 
the activity inthe presence of 20 mM CaCI2, at which concentratrion 
the SR Ca-ATPase is selectively inhibited. 
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2.3. Isolation of RNA and Northern blot analysis 
Single frozen muscles were pulverized and total RNA was extracted 
from 100 mg powder by the guanidinium thiocyanate method escrib- 
ed in [18]. The final RNA pellet was resuspended in 0.5070 sodium- 
dodecylsulphate and stored at -70°C. RNA was denatured in 1 M 
glyoxal, 5007o dimethylsulphoxide, 10 mM sodium phosphate buffer 
(pH 7.0). Up to 30 #g total RNA per lane was electrophoresed on 1 07o 
agarose gels (10 mM sodium phosphate buffer (pH 7.0)) and subse- 
quently transferred toHybond-N membrane (Amersham), fixed with 
UV light and hybridized with 32p-labelled random-primed cDNA or 
an end-labelled oligonucleotide. A 520 base BamHl(1854)- 
PvulI(2373) cDNA fragment from the coding region of type II Ca- 
ATPase (rabbit) was a kind gift from Dr D.H. MacLennan (Banting 
and Best Inst. Toronto). The sequence of this cDNA fragment is9007o 
homologous with the corresponding region of type I Ca-ATPase and 
hybridization and wash conditions were such that the probe did not 
discriminate between type I and II transcripts and can be used to 
quantify both. The level of skeletal-muscle a-actin mRNA was deter- 
mined using a synthetic oligonucleotide (5'-GCAACCATAGCA- 
CGATGGTC-3') described in [19]. Blots were hybridized with the 
cDNA probe (2 x l0 s c.p.m./#g) for 20 h in 5 x SSPE (SSPE: 180 mM 
NaCl, 0.1 mM EDTA, 10 mM sodiumphosphate buffer, pH 7.4), 5 x 
Denhardt's, 5007o formamide, 60 ttg/ml herring sperm DNA at 42°C 
and washed to a stringency of 2 x SSPE, 0.1070 sodiumdodecylsul- 
phate, 42°C. Blots were reprobed with the c~-actin oligo (1 × 106 
c.p.m./pmol) under similar conditions, but at 55°C and in the 
absence of formamide. Signals on autoradiograms (exposed for 
several periods of time) were quantified with an LKB 2202 Ultroscan 
laser densitometer. Control (euthyroid) samples and samples from 
treated animals were analyzed on the same gel. 
3. RESULTS 
Total RNA was isolated from EDL and SOL muscle 
of rats at various thyroid states. Using the non- 
discriminating cDNA probe for Ca-ATPase in Nor- 
thern analysis, two distinct signals just below the 28S 
band could be identified as shown in Fig. 1. These cor- 
respond to messages for the type I (upper signal) and 
type II Ca-ATPase [7]. Reprobing of the Northern blots 
with t~e synthetic oligonucleotide yielded a single 
strong signal just below 18S corresponding with the 
message for skeletal muscle o~-actin [16]. The latter is 
not affected by the thyroid status [19] and was used to 
normalize the Ca-ATPase mRNA levels in the various 
preparations. Figure 2 summarizes the results from the 
analyses of SOL and EDL RNA. 
3.1. Ca-A TPase mRNA in EDL 
Only type II Ca-ATPase mRNA was detected when 
RNA from this muscle was analyzed. Although 
euthyroid EDL contains about 1-3°70 slow type fibers 
(6o7o in hypothyroidism), as indicated by the presence of 
the slow myosin isozyme [9,10], no signal correspon- 
ding to type I Ca-ATPase was observed in any group, 
even at prolonged exposure of blots. Treatment with ex- 
cess T3 for two or four weeks (hyperthyroidism) had no 
effect on the total level of Ca-ATPase mRNA in this 
muscle, but hypothyroidism resulted in a 50°7o decrease 
of the Ca-ATPase mRNA level. 
3.2. Ca-A TPase mRNA in SOL 
A dramatically different picture was found for SOL 
SOL EDL 
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i :  i : 
Fig. 1. Northern blot of total RNA from SOL and EDL muscles of 
hypothyroid (H°), euthyroid (Eu) and euthyroid rats treated for two 
weeks with T3 (hyperthyroid, He), probed first with Ca-ATPase 
cDNA and again with a synthetic oligonucleotide for skeletal muscle 
a-actin (signal at 18S), as described under section 2. Autoradiograms 
of the consecutive probings were superimposed for this photograph. 
Position of type I and 1I Ca-ATPase mRNA is indicated. Longer ex- 
posure revealed type I1 message in hypothyroid SOL, but not type I 
in EDL. (This blot indicated a6-fold higher Ca-ATPase mRNA con- 
tent in EDL than in SOL (euthyroid), assuming the a-actin mRNA 
content of both muscles to be the same.) 
muscle. Rat SOL muscle comprises some 15-20°-/0 type 
II fibers [9-13,21] and the data in Fig. 2 show a similar 
percentage type II Ca-ATPase mRNA in euthyroid 
muscle. In hypothyroidism the total evel of Ca-ATPase 
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Fig. 2. Average Ca-ATPase mRNA levels of SOL and EDL obtained 
from Northern blot analyses. Autoradiograph signals of hypothyroid 
(Ho), hyperthyroid (2 weeks and 4 weeks) (Hr 2w, Hr 4w) were quan- 
tified and normalized using the a-actin signal as Trindependent 
standard, and are expressed as percentage of total euthyroid levels 
(Eu) (mean + SE, number of preparations given below). The distribu- 
tion of Ca-ATPase mRNA of type I (open column) and type II (hatch- 
ed column) in SOL is indicated; relative values of type II mRNA in 
SOL were (07o): Ho: 2+ 1 (6), Eu: 9+2 (6), Hr 2w: 57+9 (3) and Hr 
4w: 43 +_6 (6), mean +_ SE of (n) preparations, all differences were 
significant (P<0.05) except he one between 2 and 4 weeks hyper- 
thyroidism. *:P<0.05 versus euthyroid, two-sided Student's t-test. 
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Fig. 3. Total Ca-ATPase mRNA levels and Ca-ATPase activity of 
SOL (closed symbols) and EDL (open symbols). Maximal Ca-ATPase 
activities were determined in muscle homogenates of hypothyroid 
(e©), euthyroid (mrn) and hyperthyroid (two weeks (• a ) rats, as 
described under section 2, and relative values (euthyroid = 100%)are 
plotted against the relative total Ca-ATPase mRNA levels for these 
muscles ( ee Fig. 2). Absolute Ca-ATPase activities were (~mol/g wet 
weight.min):hypothyroid: SOL 4.9+_0.4 (5), EDL 57+3 (5), 
euthyroid SOL 13.5 +- 1.3 (5), EDL 79 + 3 (5), hyperthyroid (2 weeks): 
SOL 32.4+- 1.5 (4), EDL 94+ 7 (5), means + SE of (n) preparations 
(effects of hyper- and hypothyroidism were significant (P< 0.05) ex- 
cept for hyperthyroidism in EDL). Correlation coefficient of the line 
through the data points was 0.987. 
mRNA (type I and type II) dropped by 70%, and the 
percentage type II mRNA decreased relatively more, 
reaching a level of about 2% of total. T3 treatment of 
euthyroid rats more than doubled the total Ca-ATPase 
mRNA content of SOL already after two weeks, and 
prolonged treatment with T3 (4 weeks) had no further 
effect. This increase was almost entirely due to a 10-fold 
stimulation of the level of type II mRNA bringing it to 
50% of the total Ca-ATPase mRNA level. 
3.3. mRNA levels versus Ca-A TPase activity 
The effect of T3 on the level of Ca-ATPase mRNA 
was then compared to the maximal SR Ca-ATPase ac- 
tivity determined in muscle homogenates. In agreement 
with the published difference in Ca-ATPase content 
between EDL and SOL [5,14,28], we found for the 
euthyroid condition a 7-fold higher Ca-ATPase activity 
in EDL as compared to SOL, and the maximal 
T3-dependent s imulation of this activity (hyper- versus 
hypothyroid) was 6-fold for SOL and 1.5-fold for EDL 
(see legend to Fig. 3 for data). Fig. 3 shows the correla- 
tion between the relative Ca-ATPase mRNA levels and 
Ca-ATPase activities of SOL and EDL muscle from the 
four experimental groups. 
4. DISCUSSION 
Thyroid hormone has been shown to induce a 
transformation of phenotypically slow muscle fibers to 
fibers with fast contraction and relaxation 
characteristics. The full effect of T3, i.e. the transition 
from hypo- to hyperthyroidism, entails in EDL muscle 
the transformation of almost all type I fibers (6%) to 
type II, at least with respect o the isozymes of myosin 
[9]. No such isoform shift, however, appears to apply to 
the Ca-ATPases, since under all conditions only the 
type II Ca-ATPase mRNA could be detected. This is in 
agreement with recent studies on fast muscle in which it 
was also shown that expression of type I Ca-ATPase 
can be induced, but only by imposing a level of contrac- 
tile activity characteristic of slow muscle, which at the 
same time gave complete repression of type II Ca- 
ATPase [22,23]. Regulation by T3 is evidently limited in 
EDL to a stimulation of mRNA levels of the already ex- 
pressed type II isozyme of the Ca-ATPase. This in- 
crease was quantitatively similar to the observed 
stimulation of Ca-ATPase activity, which places the site 
of action of T3 at a pre-translational level in this fast- 
type muscle. 
The latter conclusion also applies to SOL muscle, 
where the T3-induced increase in total Ca-ATPase 
mRNA level correlated with the 6-fold increase in Ca- 
ATPase activity. However, the results also suggest a 
more concerted effect of T3 on the expression of Ca- 
ATPase- and myosin isozymes in the transformation of
type I fibers into fibers with fast (type II) characteristics 
in this slow muscle. Previous analyses of fiber composi- 
tion at the level of myosin have shown an increase in 
type II fibers from 6% in hypothyroidism, through 
20°7o in euthyroidism, to a maximum of 60% after 4 
weeks of hyperthyroidism [9-13], which correlates well 
with the gradual increase of the percentage type II Ca- 
ATPase mRNA presented here, i.e. 2%, 10% and 50%, 
resp. That the maximal effect on Ca-ATPase expression 
is already reached after two weeks, is in agreement with 
earlier analyses of myosin- and SR Ca 2 + -transport ac- 
tivity in SOL [24]. Although stimulation of both Ca- 
ATPase isozymes contributes to the T3-induced in- 
crease in SR Ca-ATPase activity in SOL muscle, the dif- 
ference in extent is striking. Whereas the level of type I 
mRNA was stimulated 3.5-fold, which is about equal to 
the maximal stimulation of this isoform by T3 in rat 
heart [25,26], the type II mRNA level was increased 
more than 150-fold. We propose that expression of the 
type II Ca-ATPase gene is repressed in SOL muscle, 
either due to intrinsic factors or to the activity pattern 
of slow muscle, as mentioned above, and that this 
repression can be relieved by T~. In situ hybridization 
studies are required to establish whether the isozyme 
shift observed here, entails a switch from type I to type 
II Ca-ATPase in specific fibers and stimulation of type 
I in others, or that both isozymes may be simultaneous- 
ly expressed in one fiber. Further work will also be 
needed to determine if T3, through its receptor, in- 
teracts directly with the Ca-ATPase genes, as has now 
been shown for several other T3-responsive genes [27]. 
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